Near-infrared light-responsive nanomaterials for cancer theranostics

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 8, Issue 1, 2016, Pages 23-45

  Kim, Heejung ^a   Chung, Kyungwha ^a   Lee, Seungjin ^a   Kim, Dong Ha ^a   Lee, Hyukjin ^a  

^a Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBES; DIAGNOSIS; GRAPHENE; IMAGING TECHNIQUES; INFRARED DEVICES; MOLECULAR IMAGING; NANOCRYSTALS; NANOPARTICLES; NANOSTRUCTURED MATERIALS; ONCOLOGY; PATIENT TREATMENT; PHOTODYNAMIC THERAPY; YARN;

EARLY DIAGNOSIS; GOLD NANOPARTICLE; MULTIFUNCTIONAL PLATFORMS; NEAR INFRARED LIGHT; PHOTODYNAMIC THERAPY (PDT); PHOTOTHERMAL THERAPY; RESPONSIVE BEHAVIORS; UPCONVERSION NANOCRYSTALS;

DISEASES;

CARBON NANOTUBE; GOLD NANOPARTICLE; GRAPHENE OXIDE; NANOCRYSTAL; NANOMATERIAL; UPCONVERSION NANOPARTICLE;

CANCER DIAGNOSIS; CANCER THERAPY; DRUG DELIVERY SYSTEM; EARLY DIAGNOSIS; IN VIVO STUDY; LIGHT EXPOSURE; MOLECULAR IMAGING; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THERANOSTIC NANOMEDICINE; ANIMAL; CELL LINE; CHEMISTRY; HUMAN; INFRARED RADIATION; MOUSE; NEOPLASMS; PHOTOCHEMOTHERAPY;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; HUMANS; INFRARED RAYS; MICE; MOLECULAR IMAGING; NANOSTRUCTURES; NEOPLASMS; PHOTOCHEMOTHERAPY; THERANOSTIC NANOMEDICINE;

EID: 84952870598     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1347     Document Type: Review

References (113)

1. Cancer IAfRo. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. (Accessed 2014 9).
2. Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010, 46:308-316.
3. Richards M. The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Cancer 2009, 101:S1-4.
4. Florea A-M, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011, 3:1351-1371.
5. Baxevanis CN, Perez SA, Papamichail M. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Cancer Immunol Immunother 2009, 58:317-324.
6. Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD. Recent advances from the national cancer institute alliance for nanotechnology in cancer. ACS Nano 2010, 4:589-594.
7. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
8. Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem Rev 2005, 105:1547-1562.
9. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2012, 64:206-212.
10. Choi J, Yang J, Bang D, Park J, Suh JS, Huh YM, Haam S. Targetable gold nanorods for epithelial cancer therapy guided by near-IR absorption imaging. Small 2012, 8:746-753.
11. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
12. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008, 23:217-228.
13. Daniel M-C, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004, 104:293-346.
14. Song CW, Lokshina A, Rhee JG, Patten M, Levitt SH. Implication of blood flow in hyperthermic treatment of tumors. IEEE Trans Biomed Eng 1984, BME-31:9-16.
15. Sortino S. Photoactivated nanomaterials for biomedical release applications. J Mater Chem 2012, 22:301-318.
16. Park K, Lee S, Kang E, Kim K, Choi K, Kwon IC. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 2009, 19:1553-1566.
17. Riki G, Tamar T, Smadar AL, Joseph K. Enzymatically controlled responsive drug delivery systems. Polym Adv Technol 2002, 13:1006-1018.
18. Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives. Sci Rep 2014, 4:4.
19. "Nanohybrids" based on pH-responsive hydrogels and inorganic nanoparticles for drug delivery and sensor applications. Nano Lett 2011, 11:3136-3141.
20. Near-infrared light-responsive core-shell nanogels for targeted drug delivery. ACS Nano 2011, 5:5094-5099.
21. Light-responsive micelles of spiropyran initiated hyperbranched polyglycerol for smart drug delivery. Biomacromolecules 2014, 15:628-634.
22. Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008, 68:6652-6660.
23. Kelly KL, Coronado E, Zhao LL, Schatz GC. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem B 2003, 107:668-677.
24. Sönnichsen C, Franzl T, Wilk T, von Plessen G, Feldmann J. Drastic reduction of plasmon damping in gold nanorods. Phys Rev Lett 2002, 88:077402.
25. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128:2115-2120.
26. Campion A, Kambhampati P. Surface-enhanced Raman scattering. Chem Soc Rev 1998, 27:241-250.
27. Van Duyne RP. Laser excitation of Raman scattering from adsorbed molecules on electrode surfaces. In: Chemical and Biochemical Applications of Lasers, vol. 4. Waltham: Academic Press; 1979, 101.
28. Li M, Xu J, Romero-Gonzalez M, Banwart SA, Huang WE. Single cell Raman spectroscopy for cell sorting and imaging. Curr Opin Biotechnol 2012, 23:56-63.
29. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008, 26:83-90.
30. Cao-Milán R, Liz-Marzán LM. Gold nanoparticle conjugates: recent advances toward clinical applications. Expert Opin Drug Deliv 2014, 11:741-752.
31. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 2009, 5:701-708.
32. Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012, 64:190-199.
33. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12:2313-2333.
34. Park JH, von Maltzahn G, Ong LL, Centrone A, Hatton TA, Ruoslahti E, Bhatia SN, Sailor MJ. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater 2010, 22:880-885.
35. Black KC, Yi J, Rivera JG, Zelasko-Leon DC, Messersmith PB. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine (Lond) 2013, 8:17-28.
36. Terentyuk G, Panfilova E, Khanadeev V, Chumakov D, Genina E, Bashkatov A, Tuchin V, Bucharskaya A, Maslyakova G, Khlebtsov N. Gold nanorods with a hematoporphyrin-loaded silica shell for dual-modality photodynamic and photothermal treatment of tumors in vivo. Nano Res 2014, 7:325-337.
37. Shen S, Tang H, Zhang X, Ren J, Pang Z, Wang D, Gao H, Qian Y, Jiang X, Yang W. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
38. von Maltzahn G, Park J-H, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009, 69:3892-3900.
39. Mackey MA, Ali MR, Austin LA, Near RD, El-Sayed MA. The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments. J Phys Chem B 2014, 118:1319-1326.
40. Li X, Takeda K, Yuba E, Harada A, Kono K. Preparation of PEG-modified PAMAM dendrimers having a gold nanorod core and their application to photothermal therapy. J Mater Chem B 2014, 2:4167-4176.
41. Jang B, Choi Y. Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics 2012, 2:190.
42. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12:2313-2333.
43. Wang B, Wang J-H, Liu Q, Huang H, Chen M, Li K, Li C, Yu X-F, Chu PK. Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials 2014, 35:1954-1966.
44. Jang B, Park J-Y, Tung C-H, Kim I-H, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 2011, 5:1086-1094.
45. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006, 110:7238-7248.
46. Jokerst JV, Cole AJ, Van de Sompel D, Gambhir SS. Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice. ACS Nano 2012, 6:10366-10377.
47. Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano 2011, 5:4919-4926.
48. Zeng S, Ren G, Xu C, Yang Q. Modifying crystal phase, shape, size, optical and magnetic properties of monodispersed multifunctional NaYbF4 nanocrystals through lanthanide doping. CrystEngComm 2011, 13:4276.
49. Keren S, Zavaleta C, Cheng Z, de La Zerda A, Gheysens O, Gambhir S. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci USA 2008, 105:5844-5849.
50. Dong L, Joseph KL, Witkowski CM, Craig MM. Cytotoxicity of single-walled carbon nanotubes suspended in various surfactants. Nanotechnology 2008, 19:255702.
51. Lam C-w, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 2006, 36:189-217.
52. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006, 103:3357-3362.
53. Firme CP, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine Nanotechnol Biol Med 2010, 6:245-256.
54. Prencipe G, Tabakman SM, Welsher K, Liu Z, Goodwin AP, Zhang L, Henry J, Dai H. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 2009, 131:4783-4787.
55. Robinson JT, Welsher K, Tabakman SM, Sherlock SP, Wang H, Luong R, Dai H. High performance in vivo near-IR (>1μm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res 2010, 3:779-793.
56. Gong F, Hongyan Z, Papavassiliou DV, Bui K, Lim C, Duong HM. Mesoscopic modeling of cancer photothermal therapy using single-walled carbon nanotubes and near infrared radiation: insights through an off-lattice Monte Carlo approach. Nanotechnology 2014, 25:205101.
57. Zhou S, Hashida Y, Kawakami S, Mihara J, Umeyama T, Imahori H, Murakami T, Yamashita F, Hashida M. Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and evaluation of their potential in cancer immunotherapy. Int J Pharm 2014, 471:214-223.
58. Liang C, Diao S, Wang C, Gong H, Liu T, Hong G, Shi X, Dai H, Liu Z. Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes. Adv Mater 2014, 26:5646-5652.
59. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
60. Wang L, Shi J, Liu R, Liu Y, Zhang J, Yu X, Gao J, Zhang C, Zhang Z. Photodynamic effect of functionalized single-walled carbon nanotubes: a potential sensitizer for photodynamic therapy. Nanoscale 2014, 6:4642-4651.
61. Liu S, Ko ACT, Li W, Zhong W, Xing M. NIR initiated and pH sensitive single-wall carbon nanotubes for doxorubicin intracellular delivery. J Mater Chem B 2014, 2:1125.
62. Smith BR, Ghosn EEB, Rallapalli H, Prescher JA, Larson T, Herzenberg LA, Gambhir SS. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol 2014, 9:481-487.
63. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2006, 2:47-52.
64. Hong G, Lee JC, Robinson JT, Raaz U, Xie L, Huang NF, Cooke JP, Dai H. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med 2012, 18:1841-1846.
65. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
66. Maiti UN, Lee WJ, Lee JM, Oh Y, Kim JY, Kim JE, Shim J, Han TH, Kim SO. 25th anniversary article: chemically modified/doped carbon nanotubes & graphene for optimized nanostructures & nanodevices. Adv Mater 2014, 26:40-67.
67. Wang Y, Li Z, Wang J, Li J, Lin Y. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol 2011, 29:205-212.
68. Yang K, Zhang S, Zhang G, Sun X, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
69. Akhavan O, Ghaderi E. Graphene nanomesh promises extremely efficient in vivo photothermal therapy. Small 2013, 9:3593-3601.
70. Vila M, Matesanz MC, Goncalves G, Feito MJ, Linares J, Marques PA, Portoles MT, Vallet-Regi M. Triggering cell death by nanographene oxide mediated hyperthermia. Nanotechnology 2014, 25:035101.
71. Jung HS, Kong WH, Sung DK, Lee M-Y, Beack SE, Keum DH, Kim KS, Yun SH, Hahn SK. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. ACS Nano 2014, 8:260-268.
72. Qin XC, Guo ZY, Liu ZM, Zhang W, Wan MM, Yang BW. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B 2013, 120:156-162.
73. Shang-Hsiu H, Yu-Wei C, Wen-Ting H, I-Wei C, San-Yuan C. Quantum-dot-tagged reduced graphene oxide nanocomposites for bright fluorescence bioimaging and photothermal therapy monitored in situ. Adv Mater 2012, 24:1748-1754.
74. Huacheng Z, Xing M, Kim Truc N, Yongfei Z, Shuhui T, Yanli Z. Water-soluble pillararene-functionalized graphene oxide for in vitro Raman and fluorescence dual-mode imaging. ChemPlusChem 2014, 79:462-469.
75. Goki E, Yun-Yue L, Cecilia M, Hisato Y, Hsin-An C, I-Sheng C, Chun-Wei C, Manish C. Blue photoluminescence from chemically derived graphene oxide. Adv Mater 2010, 22:505-509.
76. Jin-Long C, Xiu-Ping Y. Ionic strength and pH reversible response of visible and near-infrared fluorescence of graphene oxide nanosheets for monitoring the extracellular pH. Chem Commun 2011, 47:3135-3137.
77. Jun Q, Dan W, Fu-Hong C, Wang X, Li P, Zhen-Feng Z, Hao H, Ming-Lie H, Sailing H. Observation of multiphoton-induced fluorescence from graphene oxide nanoparticles and applications in in vivo functional bioimaging. Angew Chem Int Ed 2012, 51:10570-10575.
78. Prow TW. Multiphoton microscopy applications in nanodermatology. WIREs Nanomed Nanobiotechnol 2012, 4:680-690.
79. Karel S, Ryohei Y. Principles of two-photon excitation microscopy and its applications to neuroscience. Neuron 2006, 50:823-839.
80. Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
81. Rong P, Yang K, Srivastan A, Kiesewetter DO, Yue X, Wang F, Nie L, Bhirde A, Wang Z, Liu Z, et al. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics 2014, 4:229-239.
82. Dembereldorj U, Kim M, Kim S, Ganbold E-O, Lee SY, Joo S-W. A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo. J Mater Chem 2012, 22:23845.
83. Miao W, Shim G, Kang CM, Lee S, Choe YS, Choi HG, Oh YK. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34:9638-9647.
84. Kim H, Lee D, Kim J, Kim T-I, Kim WJ. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 2013, 7:6735-6746.
85. Hong R, Han G, Fernández JM, Kim B-J, Forbes NS, Rotello VM. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc 2006, 128:1078-1079.
86. Kim H, Namgung R, Singha K, Oh I-K, Kim WJ. Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjug Chem 2011, 22:2558-2567.
87. Kurapati R, Raichur AM. Near-infrared light-responsive graphene oxide composite multilayer capsules: a novel route for remote controlled drug delivery. Chem Commun (Camb) 2013, 49:734-736.
88. Xiaoyong Z, Jilei Y, Cheng P, Weiqing H, Zhiyong Z, Wenxin L, Chunhai F, Qing H. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 2011, 49:986-995.
89. Auzel F. Upconversion and anti-stokes processes with f and d ions in solids. Chem Rev 2004, 104:139-174.
90. Zhang F, Li J, Shan J, Xu L, Zhao D. Shape, size, and phase-controlled rare-Earth fluoride nanocrystals with optical up-conversion properties. Chem Eur J 2009, 15:11010-11019.
91. Su LT, Karuturi SK, Luo J, Liu L, Liu X, Guo J, Sum TC, Deng R, Fan HJ, Liu X, et al. Photon upconversion in hetero-nanostructured photoanodes for enhanced near-infrared light harvesting. Adv Mater 2013, 25:1603-1607.
92. 2core-shell nanoparticles. ACS Catal 2013, 3:405-412.
93. Wang C, Tao H, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
94. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med 2012, 18:1580-1585.
95. Svenmarker P, Xu CT, Andersson-Engels S. Use of nonlinear upconverting nanoparticles provides increased spatial resolution in fluorescence diffuse imaging. Opt Lett 2010, 35:2789-2791.
96. Wang H, Lu W, Zeng T, Yi Z, Rao L, Liu H, Zeng S. Multi-functional NaErF 4: Yb nanorods: enhanced red upconversion emission, in vitro cell, in vivo X-ray, and T 2-weighted magnetic resonance imaging. Nanoscale 2014, 6:2855-2860.
97. Xiong L, Chen Z, Tian Q, Cao T, Xu C, Li F. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal Chem 2009, 81:8687-8694.
98. Jin J, Xu Z, Zhang Y, Gu YJ, Lam MH, Wong WT. Upconversion nanoparticles conjugated with Gd(3+)-DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts. Adv Healthcare Mater 2013, 2:1501-1512.
99. Cheng L, Yang K, Zhang S, Shao M, Lee S, Liu Z. Highly-sensitive multiplexed in vivo imaging using pegylated upconversion nanoparticles. Nano Res 2010, 3:722-732.
100. Zhao L, Peng J, Huang Q, Li C, Chen M, Sun Y, Lin Q, Zhu L, Li F. Near-infrared photoregulated drug release in living tumor tissue via yolk-shell upconversion nanocages. Adv Funct Mater 2014, 24:363-371.
101. Garcia JV, Yang J, Shen D, Yao C, Li X, Wang R, Stucky GD, Zhao D, Ford PC, Zhang F. NIR-triggered release of caged nitric oxide using upconverting nanostructured materials. Small 2012, 8:3800-3805.
102. Jayakumar MKG, Idris NM, Zhang Y. Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers. Proc Natl Acad Sci USA 2012, 109:8483-8488.
103. Boyer J-CC, van Veggel FC. Absolute quantum yield measurements of colloidal NaYF4: Er3+, Yb3+ upconverting nanoparticles. Nanoscale 2010, 2:1417-1419.
104. Plasmon enhancement mechanism for the upconversion processes in NaYF4:Yb3+, Er3+nanoparticles: Maxwell versus Förster. ACS Nano 2014, 8:77807792.
105. MacDougall SK, Ivaturi A, Marques-Hueso J, Krämer KW, Richards BS. Ultra-high photoluminescent quantum yield of β-NaYF4: 10% Er3+ via broadband excitation of upconversion for photovoltaic devices. Opt Express 2012, 20(Suppl 6):87.
106. Liu S, Chen G, Ohulchanskyy TY, Swihart MT, Prasad PN. Facile synthesis and potential bioimaging applications of hybrid upconverting and plasmonic NaGdF4: Yb3+, Er3+/silica/gold nanoparticles. Theranostics 2013, 3:275-281.
107. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
108. Wilson B. Photodynamic therapy for cancer: principles. Can J Gastroenterol Hepatol 2002, 16:393-396.
109. Nichols JW, Bae YH. Nanotechnology for cancer treatment: possibilities and limitations. In: Cancer Targeted Drug Delivery. New York: Springer; 2013, 37-56.
110. Kostarelos K. The long and short of carbon nanotube toxicity. Nat Biotechnol 2008, 26:774-776.
111. Liu Y, Luo Y, Wu J, Wang Y, Yang X, Yang R, Wang B, Yang J, Zhang N. Graphene oxide can induce in vitro and in vivo mutagenesis. Sci Rep 2013, 3:3469.
112. Donaldson K, Murphy F, Duffin R, Poland C. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
113. Ali-Boucetta H, Nunes A, Sainz R, Herrero MA, Tian B, Prato M, Bianco A, Kostarelos K. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed 2013, 52:2274-2278.